Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hypertrichosis
ADR ID BADD_A02161
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.04      Hypertrichoses
23.02.04.002      Hypertrichosis
Description A disorder characterized by hair density or length beyond the accepted limits of normal in a particular body region, for a particular age or race. [CTCAE] Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN. [MeSH]
MedDRA Code 10020864
MeSH ID D006983
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Hairiness | Hypertrichosis | Hypertrichosis aggravated | Hypertrichosis genital | Hypertrichosis of eyelid | Body hair increased | Paratrichosis | Hypertrichoses
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Uroporphyrinogen decarboxylaseP06132Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01766Phenytoin sodium--
BADD_D01792Polidocanol--
BADD_D01821Pramoxine hydrochloride--
BADD_D01830Prednicarbate--
BADD_D01834Prednisone--
BADD_D01925Rescinnamine--
BADD_D01951Risperidone--
BADD_D02010Sertraline--
BADD_D02011Sertraline hydrochloride--
BADD_D02047Sodium oxybate0.001211%
BADD_D02066Spironolactone--
BADD_D02105Tacrolimus0.001419%
BADD_D02236Tofacitinib0.002316%
BADD_D02247Topiramate--
BADD_D02265Travoprost--
BADD_D02271Triamcinolone--
BADD_D02272Triamcinolone acetonide--
BADD_D02273Triamcinolone diacetate--
BADD_D02274Triamcinolone hexacetonide--
BADD_D02492Deflazacort0.000331%
The 3th Page    First    Pre   3    Total 3 Pages